MedTrace Logo

Angiogenic Biomarkers in Juvenile Idiopathic Arthritis

NCT05534347 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-09-12

No results posted yet for this study

Summary

The aim of the study is to determine whether serum inflammatory angiogenic markers (eg, semaphorins, CCN1) predict severity of juvenile idiopathic arthritis defined by structural progression and/or therapeutic escalation.

Conditions

  • Juvenile Idiopathic Arthritis (JIA)

Interventions

BIOLOGICAL

Blood sample

Addtional tube of blood needed for follow up of patients

BIOLOGICAL

Joint puncture

Joint puncture if needed according to routine care of the patients

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Yannick ALLANORE, PD, PhD · Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-13
Primary Completion
2030-03-31
Completion
2030-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05534347 on ClinicalTrials.gov